Posted inBiotechnology
Future Intensifies Competition for Scarce Clean Water
Water scarcity is entering a more dangerous phase—one in which the problem is no longer defined simply by how much…
Posted inBiotechnology
Sovereignty, decarbonization, and energy costs influence public support for data centers
Data centers are often portrayed as invisible engines of the digital economy, powering artificial intelligence, cloud computing, streaming platforms and…
Posted inBiotechnology
AI-Designed Minibinders Target ERO1A–PDIA1 Redox Axis in Triple-Negative Breast Cancer
Triple-negative breast cancer has long presented one of oncology’s most difficult challenges: it lacks the three molecular markers—estrogen receptor, progesterone…
Posted inBiotechnology
‘We are proud to be in the lead’: Vaderis lands $152M for phase 3 study in rare blood vessel disorder
Vaderis Therapeutics has secured an oversubscribed $152 million series B financing to propel the Swiss biotech's AKT inhibitor through phase…
Posted inGenetics
Early-Life Stress Leaves Epigenetic “Scars” That Prime Stress Sensitivity
Experiencing severe stress during childhood can make a person more vulnerable to anxiety, depression, and other mood disorders when faced…
Posted inBiotechnology
Molecular maps uncover hidden cellular programs driving heart transplant rejection
A new study is bringing molecular precision to one of the most difficult problems in transplantation: understanding why a transplanted…
Posted inBiotechnology
How Doctors’ Reassurance That Symptoms Are Normal Can Backfire
Doctors may intend the word “normal” to calm a worried patient. New research suggests that the same word can quietly…
Posted inBiotechnology
New Thai mountain dragon lizard named after House of the Dragon’s Syrax
Scientists have identified a new species of mountain horned dragon in the high-elevation forests of western Thailand, and its name…
Posted inBiotechnology
Molecular Residual Disease Testing Guides Care After EGFR-Mutated Lung Cancer Surgery
Lung cancer can leave behind a molecular fingerprint long after a surgeon has removed every visible tumor. In a study…
Posted inBiotechnology
MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial
MoonLake Immunotherapeutics announced positive phase 3 data of patients with psoriatic arthritis treated with its lead nanobody candidate, sonelokimab.